Page 10 - B Pfizer News Today

A booster of Pfizer-BioNTech's COVID-19 vaccine has proved highly effective in warding off disease from the dominant delta strain of the coronavirus, according to preliminary results of a late-stage trial.

A booster of Pfizer-BioNTech's COVID-19 vaccine has proved highly effective in warding off disease from the dominant delta strain of the coronavirus, according to preliminary results of a late-stage trial.

Advisers to the Centers for Disease Control and Prevention endorsed a booster plan Thursday for all three COVID-19 vaccines, nudging forward a strategy to let Americans mix-and-match brands to not only bolster their defenses but avoid rare, though serious, side effects that have been linked to both vaccine technologies deployed in the U.S.

U.S. regulators expect to rule Wednesday on authorizing booster doses of the Moderna and Johnson & Johnson COVID-19 vaccines, a Food and Drug Administration official said at a government meeting.

U.S. regulators expect to rule Wednesday on authorizing booster doses of the Moderna and Johnson & Johnson COVID-19 vaccines, a Food and Drug Administration official said at a government meeting.

The Biden administration cleared the way Wednesday for millions of Americans to get COVID-19 booster shots and said it will be ready to distribute vaccines for children ages 5 to 11 once the Food and Drug Administration and the Centers for Disease Control and Prevention sign off on an application from Pfizer and BioNTech.

The Biden administration said Wednesday it will be ready to distribute the COVID-19 vaccine to children ages 5 to 11 once the Food and Drug Administration and the Centers for Disease Control and Prevention sign off on an application from Pfizer and BioNTech to start the rollout.

The Biden administration cleared the way Wednesday for millions of Americans to get COVID-19 booster shots and said it will be ready to distribute vaccines for children ages 5 to 11 once the Food and Drug Administration and the Centers for Disease Control and Prevention sign off on an application from Pfizer and BioNTech.

The Biden administration said Wednesday it will be ready to distribute the COVID-19 vaccine to children ages 5 to 11 once the Food and Drug Administration and the Centers for Disease Control and Prevention sign off on an application from Pfizer and BioNTech to start the rollout.

U.S. health advisers on Friday tackled who should get boosters of Johnson & Johnson's single-shot COVID-19 vaccine and when - and whether using a competing brand for the second dose might provide better protection.